Investors Research Corp Harpoon Therapeutics, Inc. Transaction History

Investors Research Corp

  • $446 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
SELL
$13.81 - $23.25 $82 - $139
-6 Reduced 9.09%
60 $1,000
Q1 2021

Apr 28, 2021
SELL
$17.65 - $24.16 $88 - $120
-5 Reduced 7.04%
66 $1,000
Q3 2020

Oct 20, 2020
BUY
$11.01 - $18.52 $781 - $1,314
71 New
71 $1,000

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email